Timothy Bertram's most recent trade in Neximmune Inc was a trade of 44,983 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neximmune Inc | Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 23,122 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 12,634 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 12,634 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 9,556 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 0 | - | - | Stock Option (right to buy) | |
| ProKidney Corp Ordinary | Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 1,011,500 | 1,011,500 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp Ordinary | Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 3,639,607 | 3,639,607 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp Ordinary | Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,944,938 | 4,944,938 | - | - | Common Units in ProKidney LP | |
| ProKidney Corp Ordinary | Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,944,938 | 4,944,938 | - | - | Class B Ordinary Shares | |
| Neximmune Inc | Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) |